Unknown

Dataset Information

0

Comparison of Generic, Musculoskeletal-Specific, and Foot and Ankle-Specific Outcome Measures Over Time in Tibial Plafond Fractures.


ABSTRACT:

Background

This study performed a psychometric analysis assessing and comparing the responsiveness of the relevant components of a generic (Short Form-36 [SF36]), a musculoskeletal-specific (Short Musculoskeletal Functional Assessment [SMFA]), and a foot and ankle-specific (Foot and Ankle Outcome Score [FAOS]) outcome score when evaluating surgically treated tibial plafond fractures over time.

Methods

Fifty-one patients were followed for 12 months after their tibial plafond fracture. Responsiveness, or the ability to detect clinical change in a disease, was evaluated through the standardized response mean (SRM), the proportion meeting a minimal clinically important difference (MCID), and floor and ceiling effects.

Results

The SRM of the SF36-Physical Component Summary (PCS) was significantly greater than the SMFA-dysfunction index (DI) (P < .01) and FAOS-Activities of Daily Living (ADL) (P = .01) between baseline and 6 months, whereas the SRMs of only SF36-PCS and FAOS-ADL differed (P = .01) between 6 and 12 months. The proportion of patients achieving an MCID for SF36-PCS was higher than FAOS-ADL (P = .03) between baseline and 6 months and higher than SMFA-DI (P = .04) between 6 and 12 months. The FAOS-ADL showed substantial ceiling effects at baseline (88.2%) but much less at 6 months (5.9%) and 12 months (9.8%). Smaller ceiling effects were observed for the SMFA-DI (11.8%) at baseline, whereas none were observed for the SF36-PCS.

Conclusions

This study found that the SF36-PCS had greater responsiveness in assessing tibial plafond fractures compared to the SMFA-DI and FAOS-ADL, particularly in the first 6 months after surgery. In addition, limitations were revealed in the SMFA-DI and FAOS-ADL. This study illustrates the necessary diligence required for selection of outcome measures, as musculoskeletal and anatomy specific scores are not necessarily superior.

Level of evidence

Level II, prospective cohort study.

SUBMITTER: Sepehri A 

PROVIDER: S-EPMC8697142 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6712770 | biostudies-literature
| S-EPMC149439 | biostudies-literature
| S-EPMC6407033 | biostudies-literature
| S-EPMC8727837 | biostudies-literature
| S-EPMC5588950 | biostudies-literature
| S-EPMC8369118 | biostudies-literature
| S-EPMC2886311 | biostudies-literature
| S-EPMC4733695 | biostudies-literature
| S-EPMC5695419 | biostudies-literature
| S-EPMC8781557 | biostudies-literature